Elevated baseline levels of acute-phase proteins such as C-reactive protein (CRP) or cytokines like interleukin-6 (IL-6) are known risk factors for atherosclerosis and cardiovascular disease (CVD) events. However, until today, there is only controversial information about the contribution of genetic and environmental factors. Therefore, we performed an open prospective study in 108 monozygotic (MZ) and 60 same-sex dizygotic (DZ) twin pairs to analyse the genetic and environmental contributions to plasma CRP and IL-6 levels. Heritability of IL-6 was 0.61, indicating that plasma IL-6 levels are to a major part influenced by genetic determinants; however, for CRP, heritability was only 0.22, pointing to a moderate genetic influence. Plasma CRP levels were strongly influenced by female gender, older age and especially the body mass index. Our data underline the central role of IL-6 in low-grade inflammation contributing to atherosclerosis and CVD.
Low-grade inflammation is thought to play an essential role in the pathogenesis of atherosclerosis and cardiovascular disease (CVD) events.
1,2 As a highly sensitive C-reactive protein (CRP) measurement is possible, several large epidemiological studies have demonstrated association between elevated plasma CRP levels reflecting low-grade inflammation and the development of CVD events such as coronary heart disease (CHD), stroke or peripheral arterial disease. [3] [4] [5] [6] [7] CRP represents not only a sensitive marker for systemic inflammation, but also contributes to the complex interaction occurring between endothelial dysfunction, lipid accumulation, cell activation and inflammatory response in the pathogenesis of atherosclerosis. [8] [9] [10] [11] Family studies have suggested that 35-45% of the variations in plasma baseline CRP levels are genetically determined [12] [13] [14] [15] and twin studies revealed a heritability of 20-52% for CRP. [16] [17] [18] In addition, it is known that (environmental) factors such as obesity, older age, female gender, smoking, diabetes mellitus, chronic infections, lower socio-economic status, greater alcohol consumption and medications such as oral contraceptives are involved in a low-grade inflammatory response with elevated plasma CRP levels.
6, [19] [20] [21] [22] [23] [24] [25] [26] An aim of determining plasma CRP levels could be related to polymorphisms in upstream cytokines such as interleukin (IL)-6. 13 ,27 IL-6 induces CRP production in hepatocytes and it is the only cytokine that can stimulate the synthesis of all other acute-phase proteins. [28] [29] [30] Thus, some authors proposed IL-6 as a useful prognostic marker of CVD outcome [31] [32] [33] [34] [35] [36] [37] and suggested a central role for IL-6 in the pathogenesis of CHD. [38] [39] [40] However, the estimated heritability for IL-6 ranged between 0.17 and 0.57 in the literature 16, 41, 42 and previous studies concerning the heritability of CRP and IL-6 have to be interpreted carefully (Table 1) . The design and exact analysis differed (twin to general family studies, VogelMotulsky heritability to other variance composition methods) and the correction for possible confounders varied greatly between the studies (different confounders considered, different methods).
Therefore, we performed baseline plasma CRP and stimulated IL-6 measurements in monozygotic (MZ) and same-sex dizygotic (DZ) twin pairs to analyse the genetic and environmental contributions to their plasma levels. Twin studies are among the best studies for disentangling the effects of genetic and environmental components because MZ twins are genetically identical and DZ twins share on the average half of their genes whereas it is supposed that they share the same environmental influences. Demonstrating greater phenotypic correlation in MZ compared with DZ pairs provides an indication that genetic factors are involved. This can be used to obtain an estimate of heritability. The study design with healthy adult individuals had the advantage of being prospective, and possible confounders such as age, body mass index (BMI), sex, smoking and alcohol consumption were recorded and could be controlled for in the analyses. 2 ) twin pairs. Plasma CRP levels were higher in MZ (median 1.12 mg/l) compared with DZ twins (median 1.00 mg/l), which may reflect the high proportion of male subjects in the same-sex DZ twins. The same was observed for stimulated plasma IL-6 levels (median 945 pg/ml for MZ compared to 809 pg/ml for DZ twins). As covariates in our multivariate generalized estimation equation model, we included sex, age, BMI, smoking and alcohol consumption. Female individuals had higher plasma CRP levels (1.43 mg/l) than male subjects (0.94 mg/l) and CRP plasma concentration increased with older age and increasing BMI (Table 3 ). We found a higher intraclass correlation coefficient for plasma CRP levels in MZ compared to DZ twins, primarily indicating a genetic contribution. However, after adjustment for all confounding covariates, estimated heritability for CRP was substantially lower (Vogel-Motulsky heritability coefficient 0.22, 95% confidence interval [À0.16-0.61]), pointing to a moderate genetic influence on the observed variability (Table 4) . Similar to previous studies, 6, 10, 15, 19, [21] [22] [23] [24] 31, 44 CRP levels were strongly influenced by factors such as female gender (Po0.0005), older age (Po0.0005) or the BMI (Po0.0001). Particularly, the BMI, which has a large degree of heritability, 55, 56 was significantly associated with higher plasma CRP levels in a linear multiple regression analysis. According to these findings, the estimated heritability for CRP adjusted for the BMI only was 0.26 (95% confidence interval [À0.11-0.62]). This phenomenon could partly explain the measured heritability of plasma CRP levels in previous studies. Obesity and adipose tissue are known to represent a low-grade chronic inflammatory state reflected by increased acutephase proteins such as CRP and cytokines such as IL-6 and tumour necrosis factor-a (TNF-a).
24,39,57-60 Khaodhiar et al. 61 reported that in morbid obesity IL-6 may be secreted in an endocrine (systemic) manner in proportion to the expansion of fat mass particularly in the abdominal region with a corresponding increase in hepatic CRP production. Greenfield et al. 43 examined the relationship between CRP and obesity in 194 healthy female twins and it seemed that obesity and adipose tissue are important determinants of baseline plasma CRP concentrations independent of genetic influences. Together with our findings of only a moderate genetic control of plasma CRP levels in corresponding with the opinion of Retterstol et al., 17 we suggested that a major part of the previously described CRP heritability was mediated by adipose tissue and the BMI.
As already mentioned, it was suggested that the genetic background of interindividual differences in plasma CRP levels is related to a major part to polymorphisms in upstream stimulating factors governing the inflammatory response. In previous studies, plasma CRP levels strongly correlated with those of IL-6, suggesting that measuring CRP may also have been indirectly measuring plasma IL-6 levels. 35, 40, 62 It was demonstrated that healthy subjects with increased plasma IL-6 levels have a twofold risk of death and CVD events, 32, 33 independent of traditional cardiovascular risk factors but additive to that for CRP. 31 Some authors even proposed that elevated plasma IL-6 levels are a stronger predictor of cardiovascular mortality than CRP 63 and IL-6 seems to be the main circulating cytokine in systemic inflammation. 39, 40 In accordance with previous studies, 16, 47, 64 we could demonstrate that plasma IL-6 levels were not influenced by age, BMI, sex, smoking or alcohol consumption (Table 3 ). In contrast to other studies, 45, 61 we could not detect a correlation between IL-6 plasma concentration and the BMI, but in our study, the BMI was within the normal range (22.9-23.7 kg/m 2 ) and perhaps this was the reason why we could not detect any correlation. It is well known that weight loss may induce a significant reduction of plasma IL-6 levels. 65, 66 Regarding IL-6, we found a higher intraclass correlation coefficient in MZ compared to DZ twins and after correction for confounding variables, heritability for IL-6 was 0.61 (95% confidence interval [0.21-1.0]) (Table 4 ). In the same patient group, we were able to demonstrate even higher heritabilities for the type 1 helper T (Th1) cytokines TNF-a (0.72) and interferon-g (IFN-g) (0.85), 67 pointing to a strong genetic determination of these acute-phase inducers in general. Nowadays, it is known that atherosclerotic lesions promote a Th1 response (rather than a Th2 response) and therefore activated T cells differentiate into Th1 effector cells and begin producing IFN-g, finally leading to inflammation especially due to elevated levels of IL-6. 68 In summary, our study demonstrates that CRP is only moderately genetically influenced, especially after adjustment for investigated covariates. Plasma CRP levels 49 Twin partners were recruited on the same date and no subject reported symptoms of current inflammatory disease. A self-administered questionnaire was used to obtain demographic information, medical history, medication use, smoking, alcohol consumption, weight (kg) and height (cm). BMI was calculated as kg/m 2 . Criteria for exclusion were a chronic infection with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, chronic liver or kidney disease, autoimmune disease, cancer, pregnancy or lactation, individuals with a history of alcohol intake 440 g/day, statin medication or who were on regular immunosuppressant drugs. We assessed zygosity of participants by microsatellite typing with the Gene Print Powerplex 16 System Kit (Promega, Madison, WI, USA), described elsewhere. 49 CRP measurement: All persons had been bled in the morning in the fasting state. Samples were stored at À701C before being analysed. CRP levels corresponded closely with those described in other populations. 50 They were measured by a highly sensitive automated microparticle capture enzyme immunoassay (detection limit 0.425 mg/l; Roche Diagnostics GmbH, Mannheim, Germany). The procedure was executed blindly at the Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg-University, Mainz, Germany. Plasma levels of CRP 410 mg/l were considered to reflect clinical inflammation and patients with such measurements were excluded from analysis. Whole blood culture: Cytokine determinations were performed in a whole blood stimulation system as described previously. 51 Whole blood samples of 10 ml were drawn using heparinized, endotoxin-free collection tubes. The blood was diluted 1:1 with RPMI-1640 (no additives). Cells were stimulated with 25 ng/ml PMA+0.5 mg/ml ionomycin (Sigma-Aldrich, Mü nchen, Germany) for 24 h at 371C, 5% CO 2 . The whole blood cell culture method has proven to be reliable 51, 52 and represents a more physiological situation than examinations of isolated PBMC. Cytokine-ELISA: Cytokine-ELISAs were performed according to standard protocols using coating-and detection-antibodies (R&D Systems, Wiesbaden, Germany) and enzyme-linked antibodies supplied by DakoCytomation (DAKO, Hamburg, Germany). All samples were analysed in duplicate and cytokine concentrations were calculated by reference to a standard curve. A white blood differential cell count was performed the day blood was obtained. IL-6 concentration was corrected for the number of lymphocytes plus monocytes (owing to PMA/ ionomycin stimulation). Genetic and environmental contributions to plasma CRP and IL-6 levels MA Wörns et al are mainly influenced by the BMI. In contrast, we showed that plasma IL-6 levels are to a major part influenced by genetic determinants and suggested that IL-6 is an important genetic target for future research concerning the role of low-grade inflammation in CVD. Statistical analysis: Because of skewness, we log-transformed CRP and IL-6 concentrations for the statistical analysis to obtain roughly normally distributed values. We fitted generalized estimation equations (GEE) models to assess the impact of sex, age, BMI, smoking and alcohol consumption in all eligible subjects. Smoking status was grouped into current or non-smokers. Alcohol intake was grouped into yes or no. These confounders were first assessed separately in single-factor models and in a second analysis together (complete model). To adequately adjust for the dependence of two measurements in one pair, we used GEE (proc genmod in SAS 53 ). We estimated heritability on the basis of intrapair variance (heritability ¼ VWP (DZ)-VWP (MZ)/VWP (DZ); VWP: phenotypic variance within pairs; DZ: dizygotic twins; MZ: monozygotic twins 54 ). Heritability coefficients were also calculated corrected for the influence of sex, age, BMI, smoking and alcohol consumption. The confidence limits were calculated using empirical SE estimates. All calculations were performed using SAS 9.1 (SAS Institute, Cary, NC, USA). in table 3 for CRP* and IL-6**. See Table 3 foot note for statistical analysis.
